Evidence map›Paper›PMID 28743254›Full record

ArticleBMC genetics2017

Association between serotonin transporter gene polymorphisms and increased suicidal risk among HIV positive patients in Uganda.

Allan Kalungi, Soraya Seedat, Sian M J Hemmings, Lize van der Merwe, Moses L Joloba, Ann Nanteza, Noeline Nakassujja, Harriet Birabwa, Jennifer Serwanga, Pontiano Kaleebu and 1 more

Open access · diamondAbstract read
In one paragraph

Article in BMC genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. TheFrontiers in genetics · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Allan KalungiDepartment of Biotechnical and Diagnostic Sciences, College of Veterinary Medicine, Animal Resources and Biosafety (COVAB), Makerere University, Kampala, Uganda. allankalungi1@gmail.com.ORCID 0000-0002-2890-0145
Soraya SeedatDepartment of Psychiatry, Stellenbosch University, Cape Town, South Africa.
Sian M J HemmingsDivision of Molecular Biology and Human Genetics, Faculty of Health Sciences, University of Stellenbosch, Cape Town, South Africa.
Lize van der MerweDepartment of Statistics, University of the Western Cape, Cape Town, South Africa.
Moses L JolobaSchool of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Ann NantezaDepartment of Biotechnical and Diagnostic Sciences, College of Veterinary Medicine, Animal Resources and Biosafety (COVAB), Makerere University, Kampala, Uganda.
Noeline NakassujjaDepartment of Psychiatry, College of Health Sciences, Makerere University, Kampala, Uganda.
Harriet BirabwaButabika National Psychiatric Referral Hospital, Kampala, Uganda.
Jennifer SerwangaBasic Science Programme, MRC/UVRI Uganda Research Unit on AIDS, Kampala, Uganda.
Pontiano KaleebuBasic Science Programme, MRC/UVRI Uganda Research Unit on AIDS, Kampala, Uganda.
Eugene KinyandaMental Health Project, Medical Research Council/Uganda Virus Research Institute (MRC/UVRI) Research Unit on AIDS, Kampala, Uganda.
Makerere University · UGStellenbosch University · ZAUganda Virus Research Institute · UGButabika Hospital · UGLondon School of Hygiene & Tropical Medicine · GBUniversity of the Western Cape · ZA

Funding

Medical Research Council MC_U950088495Medical Research Council MR/L004623/1
6 · The paper itself

Abstract

backgroundPersons living with HIV/AIDS (PLWHA) are at an increased risk of suicide. Increased suicidal risk is a predictor of future attempted and completed suicides and has been associated with poor quality of life and poor adherence with antiretroviral therapy. Clinical risk factors have low predictive value for suicide, hence the interest in potential neurobiological correlates and specific heritable markers of suicide vulnerability. The serotonin transporter gene has previously been implicated in the aetiology of increased suicidal risk in non-HIV infected study populations and its variations may provide a platform for identifying genetic risk for suicidality among PLWHA. The present cross-sectional study aimed at identifying two common genetic variants of the serotonin transporter gene and their association with increased suicidal risk among human immunodeficiency virus (HIV)-positive adults in Uganda.

resultsThe prevalence of increased suicidal risk (defined as moderate to high risk suicidality on the suicidality module of the Mini Neuropsychiatric Interview (M.I.N.I) was 3.3% (95% CI, 2.0-5.3). The 5-HTTLPR was found to be associated with increased suicidal risk before Bonferroni correction (p-value = 0.0174). A protective effect on increased suicidal risk was found for the 5-HTTLPR/rs25531 S

conclusionThe S

Indexed as

Polymorphism, GeneticSuicideAdolescentAdultCross-Sectional StudiesFemaleGenotypeHIV-1HIV InfectionsHumansMaleQuality of LifeRisk FactorsSerotonin Plasma Membrane Transport ProteinsSurveys and QuestionnairesUgandaSerotonin Plasma Membrane Transport ProteinsSLC6A4 protein, humanHIV/AidsSerotonin transporter (5-HTT) gene polymorphismsSuicidal riskUganda

Identifiers

PMID28743254
PMCPMC5526289
OpenAlexW2739337809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.